Literature DB >> 26831534

The timing of surgical intervention in the treatment of complete motor paralysis in patients with spinal metastasis.

Yu Fan1, Xi Zhou1, Hai Wang1, Pengxiang Jiang1, Siyi Cai1, Jianguo Zhang1, Yong Liu2,3.   

Abstract

PURPOSE: The timing of surgical intervention is important for ambulatory patients with metastatic epidural spinal cord compression (MESCC), while limited studies have focused on non-ambulant patients. The aim of this study was to investigate the proper timing of surgical intervention for paraplegic patients with MESCC.
METHODS: Forty-three non-ambulant patients with MESCC who underwent posterior decompression were retrospectively reviewed. The neurological outcomes for pre-operative Frankel B patients with different interval window were further compared.
RESULTS: Neurologic deficit improved by at least 1 Frankel grade in 37 patients who underwent surgery within 72 h (86.0 %). Overall, 18 pre-operative Frankel B patients became ambulatory again with an interval of less than 48 h, 15 pre-operative Frankel B patients remained non-ambulatory post-operatively with an interval longer than 48 h besides one with an interval of 8 h (P < 0.001). All nine pre-operative Frankel A patients remained non-ambulatory even though the interval window was less than 24 h.
CONCLUSION: The timing of surgical intervention was key to predicting the post-operative outcome, and 48 h was suggested as the proper interval window for pre-operative Frankel B patients. These patients preserved sensory function which might be a predictor. And the sooner the surgery was performed, the better the result would be.

Entities:  

Keywords:  Complete motor paralytic; Spinal tumor; Surgical intervention; Timing

Mesh:

Year:  2016        PMID: 26831534     DOI: 10.1007/s00586-016-4406-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  20 in total

1.  Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients.

Authors:  S Helweg-Larsen
Journal:  Acta Neurol Scand       Date:  1996-10       Impact factor: 3.209

Review 2.  Surgery insight: current management of epidural spinal cord compression from metastatic spine disease.

Authors:  Timothy F Witham; Yevgeniy A Khavkin; Gary L Gallia; Jean-Paul Wolinsky; Ziya L Gokaslan
Journal:  Nat Clin Pract Neurol       Date:  2006-02

3.  The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I.

Authors:  H L Frankel; D O Hancock; G Hyslop; J Melzak; L S Michaelis; G H Ungar; J D Vernon; J J Walsh
Journal:  Paraplegia       Date:  1969-11

4.  Effect of timing of surgery on neurological outcome and survival in metastatic spinal cord compression.

Authors:  N A Quraishi; T S Rajagopal; S R Manoharan; S Elsayed; K L Edwards; B M Boszczyk
Journal:  Eur Spine J       Date:  2012-12-30       Impact factor: 3.134

Review 5.  Metastatic epidural spinal cord compression: update on management.

Authors:  Thomas N Byrne; Lawrence F Borges; Jay S Loeffler
Journal:  Semin Oncol       Date:  2006-06       Impact factor: 4.929

6.  Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease.

Authors:  Daniel M Sciubba; Ziya L Gokaslan; Ian Suk; Dima Suki; Marcos V C Maldaun; Ian E McCutcheon; Remi Nader; Richard Theriault; Laurence D Rhines; Joseph A Shehadi
Journal:  Eur Spine J       Date:  2007-05-08       Impact factor: 3.134

Review 7.  Metastatic epidural spinal cord compression.

Authors:  John S Cole; Roy A Patchell
Journal:  Lancet Neurol       Date:  2008-05       Impact factor: 44.182

8.  Destructive pathological changes in the rat spinal cord due to chronic mechanical compression. Laboratory investigation.

Authors:  Peng Xu; Wei-Ming Gong; Yao Li; Tao Zhang; Kai Zhang; De-Zhen Yin; Tang-Hong Jia
Journal:  J Neurosurg Spine       Date:  2008-03

9.  [Three patients successfully treated with orthopedic surgery for spinal paralysis due to spine metastasis of gastric cancer].

Authors:  Hiroshi Imamura; Johji Kohno; Tomono Kishimoto; Ryohei Kawabata; Mutsumi Fukunaga; Hiroki Ohzato; Hiroshi Furukawa
Journal:  Gan To Kagaku Ryoho       Date:  2009-11

10.  Malignant spinal cord compression: a retrospective audit of clinical practice at a UK regional cancer centre.

Authors:  A McLinton; C Hutchison
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

View more
  5 in total

1.  Reducing kyphotic deformity by posterior vertebral column resection with 360° osteosynthesis in metastatic epidural spinal cord compression (MESCC).

Authors:  Marc Dreimann; Michael Hoffmann; Lennart Viezens; Lukas Weiser; Patrick Czorlich; Sven Oliver Eicker
Journal:  Eur Spine J       Date:  2016-10-11       Impact factor: 3.134

2.  Impact of spinal cord compression from intradural and epidural spinal tumors on perioperative symptoms-implications for surgical decision making.

Authors:  Malte Mohme; Klaus Christian Mende; Theresa Krätzig; Rosemarie Plaetke; Kerim Beseoglu; Julian Hagedorn; Hans-Jakob Steiger; Frank W Floeth; Sven O Eicker
Journal:  Neurosurg Rev       Date:  2016-10-07       Impact factor: 3.042

3.  Metastatic epidural spinal cord compression: does timing of surgery influence the chance of neurological recovery? An observational case-control study.

Authors:  Valerio Pipola; Silvia Terzi; Giuseppe Tedesco; Stefano Bandiera; Giovanni Barbanti Bròdano; Riccardo Ghermandi; Gisberto Evangelisti; Marco Girolami; Alessandro Gasbarrini
Journal:  Support Care Cancer       Date:  2018-03-30       Impact factor: 3.603

4.  Surgery in Acute Metastatic Spinal Cord Compression: Timing and Functional Outcome.

Authors:  Hanno S Meyer; Arthur Wagner; Alessandra Raufer; Ann-Kathrin Joerger; Jens Gempt; Bernhard Meyer
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.639

5.  Impact of decompressive laminectomy on the functional outcome of patients with metastatic spinal cord compression and neurological impairment.

Authors:  Alexander Younsi; Lennart Riemann; Moritz Scherer; Andreas Unterberg; Klaus Zweckberger
Journal:  Clin Exp Metastasis       Date:  2020-01-20       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.